LD-2 disclosure · 4th Quarter - Report

TRAVERE THERAPEUTICS

4th Quarter (Oct 1 - Dec 31) · 2021Posted Jan 19, 2022Filing document ↗LDA record ↗

Expenses$100Kself-filed spend

Client

6 issues

Taxation/Internal Revenue Code
Provisions of H.R. 5736 Build Back Better Act and related Senate legislation regarding the Orphan Drug Tax Credit; related rare disease research incentives. Legislation regarding tax treatment of net operating losses.
LobbyistsCHRISTOPHER PORTER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)
Copyright/Patent/Trademark
H.R. 2873, the Affordable Prescriptions for Patients Through Promoting Competition Act of 2021; other 1egislation regarding intellectual property and trademark issues, including waivers of international trade agreements.
LobbyistsCHRISTOPHER PORTER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)
Health Issues
Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Newborn Screening Saves Lives Act Reauthorization, H.R. 482, S 350. FY 2022 CDC Appropriations for state newborn screening technical assistance and related Senate appropriations. H.R. 1692, S 250, Fairness in Orphan Drug Exclusivity Act.
LobbyistsCHRISTOPHER PORTER

LD-2 disclosure · 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) · 2021Posted Jan 19, 2022Filing document ↗LDA record ↗

Expenses$100Kself-filed spend

6 issues

Taxation/Internal Revenue Code
Provisions of H.R. 5736 Build Back Better Act and related Senate legislation regarding the Orphan Drug Tax Credit; related rare disease research incentives. Legislation regarding tax treatment of net operating losses.
LobbyistsCHRISTOPHER PORTER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)
Copyright/Patent/Trademark
H.R. 2873, the Affordable Prescriptions for Patients Through Promoting Competition Act of 2021; other 1egislation regarding intellectual property and trademark issues, including waivers of international trade agreements.
LobbyistsCHRISTOPHER PORTER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)
Health Issues
Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Newborn Screening Saves Lives Act Reauthorization, H.R. 482, S 350. FY 2022 CDC Appropriations for state newborn screening technical assistance and related Senate appropriations. H.R. 1692, S 250, Fairness in Orphan Drug Exclusivity Act.
LobbyistsCHRISTOPHER PORTER